Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177 Labeled Albumin-Binding, PSMA-Targeted CTT1403

PURPOSE: Prostate-specific membrane antigen (PSMA) continues to be the hallmark biomarker for prostate cancer as it is expressed on nearly all prostatic tumors. In addition, increased PSMA expression correlates with castration resistance and progression to the metastatic stage of the disease. Recent...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Imaging Biol
Auteurs principaux: Ling, Xiaoxi, Latoche, Joseph D., Choy, Cindy J., Kurland, Brenda F., Laymon, Charles M., Wu, Yijen, Salamacha, Nathan, Shen, Ding, Geruntho, Jonathan J., Rigatti, Lora H., Windish, Hillarie P., Langton-Webster, Beatrice, Berkman, Clifford E., Anderson, Carolyn J.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6980512/
https://ncbi.nlm.nih.gov/pubmed/31321650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-019-01404-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires